Sea Crest Wealth Management, LLC Mirati Therapeutics, Inc. Transaction History

Sea Crest Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$59.49 - $104.71 $80,311 - $141,358	-1,350 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$43.65 - $78.95 $2,182 - $3,947	-50 Reduced 3.57%	1,350 $99,000
Q1 2018 Apr 20, 2018	BUY	$17.2 - $34.95 $10,320 - $20,970	600 Added 75.0%	1,400 $43,000
Q4 2017 Feb 02, 2018	BUY	$12.65 - $19.0 $10,120 - $15,200	800	800 $15,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.